期刊文献+

miR-192负性调控人肝癌细胞株HepG2中RB1基因的表达 被引量:2

Negative Regulation of Expression of RB1 by miR-192 in Human Hepatocellular Carcinoma Cell Line HepG2
暂未订购
导出
摘要 目的探讨miR-192对人肝癌细胞株HepG2中RB1基因表达的调节作用。方法运用生物信息学方法对miR-192进行靶基因预测并分析其潜在靶基因RB1;将含有miR-192结合位点的RB1mRNA 3′端非编码区(3′UTR)片段和在miR-192结合位点进行突变的RB1 3′UTR突变片段克隆至报告基因载体pMIR-Report luciferase vector,重组质粒分别命名为pMIR-RB1和pMIR-RB1-mut;将重组质粒、Beta-gal内参质粒和microRNA共转染HepG2细胞,双荧光素酶报告基因系统检测各实验组中细胞荧光素酶的表达;SYBR Green荧光定量PCR和Western blot分别在mRNA和蛋白水平检测miR-192对内源性RB1表达的调节作用。结果生物信息学分析筛选出89个miR-192的潜在靶基因,RB1基因是其中之一;测序验证重组质粒pMIR-RB1和pMIR-RB1-mut构建成功;过表达miR-192时,共转染pMIR-RB1质粒的细胞相对荧光素酶活性(4.80±0.36)较相应过表达miR-NC组(7.90±0.91)明显降低(P<0.05),而共转染pMIR-Luc或pMIR-RB1-mut质粒的细胞相对荧光素酶活性[pMIR-Luc:(7.68±1.04);pMIR-RB1-mut:(7.56±0.99)]较相应过表达miR-NC组[pMIR-Luc:(7.86±0.73);pMIR-RB1-mut:(7.82±1.05)]无显著差异;上调miR-192水平显著降低HepG2细胞中内源性RB1mRNA[(0.56±0.10)vs(1.05±0.13)]和蛋白(47%vs 100%)的表达。结论 RB1基因是miR-192的一个靶基因,在HepG2细胞中,miR-192通过直接结合RB1mRNA 3′UTR而负性调控RB1基因表达。 Objective To explore the regulatory effect of miR-192 on the expression of RB1 in human hepatocellular carcinoma cell line HepG2.Methods Bioformatics analysis was used for miR-192 target prediction.Among all the potential targets,RB1 was chosen for further investigation.The fragments of 3′-untranslated region(3′UTR)of RB1 mRNA encompassing a putative miR-192 binding site and the mutant forms were cloned into pMIR-Report luciferase vector.The recombinant plasmids were named as pMIR-RB1 and pMIR-RB1-mut,respectively.Recombinant plasmids,Beta-gal control plasmid and microRNAs were co-transfected into HepG2 cells.The luciferase and β-galactosidase activities of each group were detected by using dual-light luciferase assay.SYBR Green quantitative PCR and Western blot were performed to examine the regulatory effect of miR-192 on the expression of endogenous RB1 mRNA and protein.Results Eighty-nine genes were isolated as potential targets of miR-192 by using bioformatics analysis and one of them was RB1 gene.The recombinant plasmids pMIR-RB1 and pMIR-RB1-mut were confirmed by sequencing.As compared with miR-NC group(7.90±0.91),overexpression of miR-192 significantly reduced the relative luciferase activity of cells co-transfected with pMIR-RB1 vector(4.80±0.36).In contrast,the relative luciferase activity of cells co-transfected with pMIR-Luc or pMIR-RB1-mut vector in miR-192 group[pMIR-Luc:(7.68±1.04);pMIR-RB1-mut:(7.56±0.99)]had no significant changes as compared with that in miR-NC group[pMIR-Luc:(7.86±0.73);pMIR-RB1-mut:(7.82±1.05)].Overexpression of miR-192 suppressed dramatically the expression of endogenous RB1 at mRNA[(0.56±0.10) vs(1.05±0.13)]and protein levels(47% vs 100%)in HepG2 cells.Conclusion RB1 gene was a target of miR-192,and miR-192 negatively regulated the expression of RB1 gene by directly binding to RB1 mRNA 3′ UTR in HepG2 cells.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2011年第6期656-661,共6页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家自然科学基金资助项目(No.30872237 No.81101824)
关键词 miR-192 RB1基因 HEPG2细胞 基因表达 miR-192 RB1 gene HepG2 cells gene expression
  • 相关文献

参考文献21

  • 1Bartel D P.MicroRNAs:genomics,biogenesis,mechanism,an-d function[J].Cell,2004,116(2):281-297.
  • 2Slack F J,Weidhaas J B.MicroRNA in cancer prognosis[J].N Engl J Med,2008,359(25):2720-2722.
  • 3Barad O,Meiri E,Avniel A,et al.MicroRNA expression detected by oligonucleotide microarrays:system establishment and expression profiling in human tissues[J].Genome Res,2004,14(12):2486-2494.
  • 4Chung A C,Huang X R,Meng X,et al.miR-192 mediates T-GF-beta/Smad3-driven renal fibrosis[J].J Am Soc Nephrol,2010,21(8):1317-1325.
  • 5Braun C J,Zhang X,Savelyeva I,et al.p53-Responsive mic-rornas 192 and 215 are capable of inducing cell cycle arrest[J].Cancer Res,2008,68(24):10094-10104.
  • 6Xie Q H,He X X,Chang Y,et al.MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells[J].Biochem Biophys Res Commun,2011,410(3):440-445.
  • 7Georges S A,Biery M C,Kim S Y,et al.Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs,miR-192 and miR-215[J].Cancer Res,2008,68(24):10105-10112.
  • 8谢琼慧,何星星,常莹,蒋翔,林菊生.HBx基因下调miR-192对人肝癌细胞株HepG2周期的影响[J].华中科技大学学报(医学版),2011,40(3):249-254. 被引量:7
  • 9Song B,Wang Y,Kudo K,et al.miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit[J].Clin Cancer Res,2008,14(24):8080-8086.
  • 10Martin C S,Wight P A,Dobretsova A,et al.Dual luminescence-based reporter gene assay for luciferase and beta-galactosidase[J].Biotechniques,1996 21(3):520-524.

二级参考文献19

  • 1Bouchard M J, Schneider R J. The enigmatic X gene of hepati- tis B virus[J]. J Virol,2004,78(23) :12725-12734.
  • 2Esquela-Kerscher A, Slack F J. Oncomirs-microRNAs with a role in cancer[J]. Nat Rev Cancer, 2006,6 (4) : 259-269.
  • 3Zimmerman A L, Wu S. MicroRNAs, cancer and cancer stem cells[J]. Cancer Lett,2011,300(1) : 10-19.
  • 4Varnholt H,Drebber U, Schulze F, et al. MicroRNA gene ex- pression profile of hepatitis C virus-associated hepatoeellular carcinoma[J]. Hepatotogy,2008,47(4) : 1223-1232.
  • 5Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations[J]. Hepatol- ogy, 2008,47(6) : 1955-1963.
  • 6Barad O, Meiri E, Avniel A, et al. MicroRNA expression de- tected by oligonucleotide microarrays: system establishment and expression profiling in human tissues[J]. Genome Res, 2004,14(12) :2486-2494.
  • 7Wang Y,Lu Y,Toh S T,et al. Lethal-7 is down-regulated by the hepatitis B virus X protein and targets signal transducer and acti- vator of transcription 3[J]. J Hepatol, 2010,53 (1) : 57-66.
  • 8Yang L, Ma Z, Wang D,et al. MicroRNA-602 regulating tum- or suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular eareinoma[J]. Cancer Biol Ther,2010,9(10) :803-808.
  • 9Ganem D,Prince A M. Hepatitis B virus infection-natural hi- story and clinical consequences[J]. N Engl J Med, 2004,350 (11) :1118-1129.
  • 10Matsuda Y,Iehida T. Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis[J]. Med Mol Morphol, 2009,42(3) : 138-142.

共引文献6

同被引文献5

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部